glp-1 weight loss drug news drugs to become cheaper for some under temporary Medicare program Medicare is now covering certain
Description
Ongoing efforts are made to strengthen domestic manufacturing infrastructure, promoting the indigenous manufacturing of GLP-1 drugs
Like exenatide, lixisenatide demonstrates reliable control of blood glucose and provides modest weight loss, typically less than 3 kg depending on the duration of treatment (Sheng et al., 2024)
And because a drug is doing the work, stopping it lets appetite, and weight, come back
#T2DM #MedTwitter #MedEd #MedX #HealthTech #Pharmacology @IhabFathiSulima @drkeithsiau @DrAkhilX @hyderabaddoctor @drmohanv
The "Start Low" Approach (Resetting to Introduction Doses) Semaglutide and tirzepatide both follow titrated dosing schedules, where healthcare providers prescribe a low starting dose and gradually increase from there based on your response to the medication and tolerance for side effects
The initial search identified 503 articles in Pubmed, which were scrutinized for relevance
